Patent ID: 8535224
Filing Date: 2013-09-17
Classification: A61B,A61N

Abstract:
1. An electro diagnostic functional assessment unit (EFA-2) comprising: at least one EMG sensor, at least one EMG/EKG sensor having means for sensing cardiac response of a person's muscle groups, wherein the outputs from said at least one EMG/EKG sensor(s) are applied to and processed by said EFA-2, at least one EMG sensor having means for producing a current for sensing the amplitude, frequency and conduction velocity of specific nerves of a person's muscle groups or nerve fibers, wherein the output from said at least one EMG sensor is applied to and processed by said EFA-2, at least one nerve conduction velocity (NCV) sensor having means for monitoring the nerve conduction velocity of a person, wherein the output from said at least one NCV sensor is applied to and processed by said EFA-2, at least one range of motion (ROM) device that generates data through the use of potentiometers, goniometers, accelerometers, video or electro magnetic sensors, wherein said ROM device is configured to measure a person's range of motion, lateral movement, flexion, extension, rotation, abduction, joint capabilities, speed and consistency in either upper or lower extremities or spine, wherein the output from said ROM device is applied to and processed by said EFA-2, at least one functional capacity evaluation (FCE) sensor having means for measuring a person's lift, push or pull capability, wherein the output of said at least one FCE sensor(s) is applied to and processed by said EFA-2, at least one grip sensor having means for measuring a person's grips strength, wherein the output of said at least one grip sensor is applied to and processed by said EFA-2, at least one pinch sensor having means for measuring a person's pinch strength, wherein the output of said at least one pinch sensor is applied to and processed by said EFA-2, and at least one treatment delivery mechanism having means for delivering site-specific treatment, wherein the output from said at least one treatment delivery mechanism is applied to and processed by said EFA-2 which is configured to perform site-specific treatment.